Healthcare

  Lung cancer  starts in the lungs and can spread to the lymph nodes or other body organs, including the brain. Cancer that has progressed to other organs can potentially spread to the lungs. Metastases are the spread of cancer cells from one organ to another. Small cell and non-small cell lung tumors are the two most common kinds of lung cancer. These kinds of lung cancer grow and respond to treatment in different ways. Non-small cell lung cancer is more prevalent than small cell lung cancer, according to the American Cancer Society. Lung cancer symptoms range from person to person. Symptoms of the lungs affect some persons. Region Analysis: North America dominates the lung cancer diagnostics market, due to rising incidence of lung cancer and the ageing population in the particular region. North America is regarded as the largest regional market with the highest market share due to increased market invasion rates of technologically advanced products, rising patient awareness, and risi

  Pneumococcal Vaccine Market   accounted for US$ US$8.1 billion in 2020 and is estimated to be US$ 13.5 billion by 2030 and is anticipated to register a CAGR of 5.3%. Serious and potentially fatal pneumococcal infections is protected by the pneumococcal vaccine. It's also known as the pneumonia vaccine. Pneumococcal infections caused by the bacterium Streptococcus pneumonia which lead to pneumonia, septicemia (a kind of blood poisoning) and meningitis. All adults (65 years or older) should receive dose of pneumococcal polysaccharide vaccine (PPSV23). In addition, CDC recommends PCV13 based on shared clinical decision-making for adults 65 years or older who do not have an immune compromising condition, cerebrospinal fluid leak, or cochlear implant. The report "  Global Pneumococcal Vaccine Market, By Vaccine type (Pneumococcal Conjugate Vaccine and Pneumococcal Polysaccharide Vaccine), By Product Type (Prevnar 13, Synflorix, Pneumovax 23), By Sector (Public and Private), By Di

  Infection control is a practical sub-discipline of epidemiology concerned with preventing healthcare-associated infection. Infection prevention and control is critical in hospitals and clinics because it prevents the spread of illnesses in these environments. Infection control refers to policies and practices used in hospitals and other healthcare settings to control and minimize the spread of illnesses with the goal of lowering infection rates. Infection control programmes were created with the primary goal of focusing on HAI surveillance and combining basic epidemiological knowledge to identify HAI risk factors. Infection control helps in preventing spread of infections in healthcare. Training and education courses on infection control for healthcare providers will help in reducing spread of infection. Contact, airborne, droplets and infection control standard are the methods of infection control. Personal protective equipment, hand hygiene, respiratory & cough hygiene, self-ma

  The  COVID-19 diagnostics  market   accounted for US$ 4.9 billion in 2020 and is estimated to be US$ 8.3 billion by 2029 and is anticipated to register a CAGR of 6.1%. The report " Global   COVID-19 Diagnostics Market, By Product (Instruments and Reagents & Kits), By Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, and Others), By Technology (Polymerase Chain Reaction (PCR), Antibody or Enzyme-Linked Immunosorbent Assay (ELISA), Serology, Portable or Point-of-Care (POC), and Others), By End-user (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2027” . Key Highlights: In April 2020, the FDA declared that U.S. Cotton has planned to develop polyester-based swabs in large quantities that can also be put to use in sample collection for coronavirus testing. These initiatives are projected to f

  The   Osteoporosis Treatment Market   accounted for US$ 11.60 billion in 2020 and is estimated to be US$ 17.68 billion by 2030 and is anticipated to register a CAGR of 4.3%. Osteoporosis is a condition in which body loses too much bone and there is an increase in bone weakness. The individual suffering from osteoporosis is more exposed to bone fractures. Hence, a proper treatment is required to cure and avoid the chances of complications. Osteoporosis, or thinning bones, can result in painful fractures. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications. The report “ Global Osteoporosis Treatment Market By Drugs Type (Selective Estrogen Receptor Modulators (SERMs), Rank Ligand (RANKL) Inhibitor, Calcitonin, Hormone Therapy, Parathyroid Hormone-Related Protein (PTHrP) Analog, and Bisphosphonates (Risedrona

  The   Oncology Drugs Market   accounted for US$ 181.47 billion in 2020 and is estimated to be US$ 869.6 million by 2030 with a CAGR of 8.9% during the forecast period. Cancer drug is any of several drugs that control or kill neoplastic cells; used in chemotherapy to kill cancer cells; all have unpleasant side effects that may include nausea and vomiting and hair loss and suppression of bone marrow function. synonyms: antineoplastic, antineoplastic drug. Many different kinds of chemotherapy or chemo drugs are used to treat cancer – either alone or in combination with other drugs or treatments. The report "   Global Oncology Drugs Market, By Product Type (Cytotoxic Drugs, Targeted Drugs, and Hormonal Drugs), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), By End User (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middl

  Growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global market. The  pain management devices market  accounted for US$ 76202.27 billion in 2020 and is estimated to be US$ 154549.5 billion by 2030 and is anticipated to register a CAGR of 7.4%. The report " Global Pain Management Devices Market, By Product (Radiofrequency Ablation, Neurostimulation), By Application (Cancer, Neuropathic) and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2030” . Key Highlights: August 2020, Medtronic announced the commercial launch of its FDA-approved neurostimul